Search Results - "Gutiérrez Nicolás, Fernando"

Refine Results
  1. 1

    Anti-drug antibodies anti-trastuzumab in the treatment of breast cancer by Padrón, Ivette Mourani, García, Jonathan González, Díaz, Ruth Ramos, Lenza, Isaac Ceballos, Nicolás, Fernando Gutiérrez

    Published in Journal of oncology pharmacy practice (01-08-2021)
    “…Introduction Trastuzumab is a monoclonal antibody which could induce the activation of a humoral immune response generating anti-drug antibodies (ADAs). Such…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Reducing the degree of colonisation of venous access catheters by continuous passive disinfection by Gutiérrez Nicolás, Fernando, Nazco Casariego, Gloria Julia, Viña Romero, María Micaela, González García, Jonathan, Ramos Diaz, Ruth, Perez Perez, Jose Antonio

    “…IntroductionThe advent of Luer-type needleless venous access catheters has been accompanied by a growing number of catheter-related bloodstream infections. Our…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Definition of a therapeutic range for predicting long-term infliximab response in patients with inflammatory bowel disease by Cantarelli, Lorenzo, Carrillo Palau, Marta, Hernandez Guerra, Manuel, Nazco Casariego, Gloria Julia, Gutierrez Nicolás, Fernando

    Published in Medicina clinica (10-02-2023)
    “…Monitoring plasma levels of Infliximab plays an important role in optimising treatment in patients with inflammatory bowel disease (IBD). The aim of the…”
    Get more information
    Journal Article
  9. 9

    Allelic Frequency of DPYD Genetic Variants in Patients With Cancer in Spain: The PhotoDPYD Study by Miarons, Marta, Manzaneque Gordón, Alba, Riera, Pau, Gutiérrez Nicolás, Fernando

    Published in The oncologist (Dayton, Ohio) (01-05-2023)
    “…Abstract Introduction Identifying polymorphisms in the dihydropyrimidine dehydrogenase (DPYD) gene is gaining importance to be able to predict…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Pharmacist-led medication reconciliation to reduce discrepancies in transitions of care in Spain by Allende Bandrés, Maria Ángeles, Arenere Mendoza, Mercedes, Gutiérrez Nicolás, Fernando, Calleja Hernández, Miguel Ángel, Ruiz La Iglesia, Fernando

    Published in International journal of clinical pharmacy (01-12-2013)
    “…Background Medication errors are one of the main causes of morbidity amongst hospital inpatients. More than half of medication errors occur at ‘interfaces of…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Ten-minute administration of bevacizumab by García Gil, Sara, Gutiérrez Nicolás, Fernando, González De La Fuente, Guillermo A, Nazco Casariego, Gloria J, Viña Romero, M Micaela, Batista López, J Norberto

    “…ObjectiveTo describe our experience of administering bevacizumab doses at 0.5 mg/kg/min. The main objective of the study was to evaluate the safety of this…”
    Get full text
    Journal Article
  14. 14

    Adequacy to diagnostic recommendations in patients with Pneumocystis jirovecii pneumonia treated with intravenous pentamidine by Cantarelli, L, Gutiérrez Nicolás, F, Nazco Casariego, G J, García Gil, S

    Published in Revista española de quimioterapia (01-02-2022)
    “…To determine the rate of microbiological confirmation in the diagnosis of Pneumocystis jirovecii pneumonia in patients treated with intravenous pentamidine and…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Adherence to subcutaneous biologic treatment for inflammatory bowel disease by Ramos, Laura, Ramos-Rodríguez, Javier, Barreda, Raquel De La, Gutiérrez-Nicolás, Fernando, Carrillo-Palau, Marta, Alonso-Abreu, Inmaculada, Nazco-Casariego, Julia, Quintero, Enrique

    “…Nonadherence to medication is common in patients with inflammatory bowel disease (IBD) and can result in disease complications, therapy escalation, and the…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Efficacy and safety of high doses of irinotecan in patients with metastatic colorectal cancer treated with the FOLFIRI regimen based on the UGT1A1 genotype: A systematic review by Miarons, Marta, Riera, Pau, García-Gil, Sara, Gutiérrez-Nicolás, Fernando

    Published in Farmacia hospitalaria (01-07-2022)
    “…The purpose of this systematic review is to analyze the published data on the efficacy and safety of doses higher than 180 mg/m2 of irinotecan recommended in…”
    Get full text
    Journal Article
  20. 20